Blog

7 minutes read

Inside Scoop: The Syapse Clinical Abstraction Team

Katie Levie

Katie Levie

August 04, 2021

Forming its Clinical Abstraction Team, Syapse employs more than 50 Certified Tumor Registrars (CTRs) with over 600 years of collective experience. As a remote-first team and company, CTRs live and work around the United States. The Clinical Abstraction team is invaluable in delivering robust, intelligent real-world data. What is the role of a clinical …

Read this article

Clinical Abstraction

09/17/2020

For People with Cancer — Further Evidence of Worse Outcomes Due to COVID-19

By Thomas Brown, MD

“Delays in screenings, diagnosis and treatment because of the coronavirus pandemic are likely to result in thousands of “excess” deaths from the disease in coming years.” Ned Sharpless, M.D., director of the National Cancer Institute

Read

05/26/2020

Qi Liu, PhD, of the U.S. Food and Drug Administration, discusses the findings from our collaborative research

By Antoinette Cummins

Qi Liu, PhD, of the U.S. Food and Drug Administration, discusses data that suggest that patients with advanced non–small cell lung cancer who had a past medical history of pneumonitis were more likely to experience treatment-associated pneumonitis in response to immune checkpoint inhibitors or chemotherapy. See the video here.…

Read

04/27/2020

Syapse, FDA, and Advocate Aurora Health to Present Safety Research at AACR Plenary Session

By Thomas Brown, MD

Over the course of my career, I have worked to advance the development of novel cancer therapeutics through classic phase I, II, and III clinical trials at academic centers. More recently, leading a “hybrid” cancer research program in a community setting, including leadership of a precision medicine program, I realized the potential for real-…

Read

Let's chat.

If you’d like to learn more about Syapse, tell us a little about yourself and we will reach out as soon as possible.